← Open Payments lookup

KUMLI ANYE: Open Payments

NPI 1104221613 · LAUREL, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$645 in 24 payments from 10 companies in 2025. Trend: 2023 $103 · 2024 $147 · 2025 $645

Food & beverage: $533Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.5$189
ABBVIE INC.5$107
Janssen Pharmaceuticals, Inc3$107
Alkermes, Inc.3$84
Lundbeck LLC3$53
Vanda Pharmaceuticals Inc.1$24
Indivior Inc.1$22
Neurocrine BioSciences, Inc.1$22
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$19
E.R. Squibb & Sons, L.L.C.1$17

Products named: VRAYLAR, INVEGA SUSTENNA, VIVITROL, UZEDY, AUSTEDO XR, REXULTI, HETLIOZ, ABILIFY ASIMTUFII.

Industry payments across MD — which companies pay providers there.